ClearBrief

Health

How to Read a Health Study Without Getting Misled

A practical guide to evaluating health research — sample sizes, study design, conflict of interest, and the questions to ask before you change your routine.

By Daniel OkaforHealth 4 min read 849 wordsFact-checked April 2, 2026
A health journalist marking up a printed medical study on a desk next to a laptop.
A health journalist marking up a printed medical study on a desk next to a laptop.

Originally published . Last reviewed and updated .

Contents(5 sections)
  1. 1. Know what kind of study you are reading
  2. 2. Sample size and population
  3. 3. Effect size versus statistical significance
  4. 4. Funding and conflict of interest
  5. 5. What the authors actually say

Health stories tend to move in waves: a single study lands, headlines amplify it, and a week later a different study seems to contradict the first. In reality, individual studies almost never settle questions on their own. They contribute evidence that researchers integrate over years.

You do not need to read studies the way a researcher does to avoid being misled. A short checklist — what kind of study, how many people, who funded it, and what the authors actually claim — is enough to navigate most health news responsibly. This article walks through that checklist.

Know what kind of study you are reading

Different study designs answer different questions. A randomized controlled trial (RCT) can test whether an intervention causes an effect, because participants are randomly assigned to groups. An observational study can identify associations but cannot, by itself, establish cause. A case report is a single patient's experience and is the weakest form of evidence for general claims.

Reviews and meta-analyses pool many studies together. When done carefully, they are the strongest evidence on a topic, because they reflect the weight of many independent results rather than one team's findings.

Sample size and population

A trial of 30 people can produce a striking result that does not survive replication in larger samples. Look for the number of participants, and look at who they were: a study in 50 elite athletes may not generalize to a 60-year-old with chronic conditions. Reputable health writing names the sample and the population in the first few paragraphs.

Sample size alone is not enough. A well-designed small RCT can outweigh a sprawling but poorly controlled observational study. The point is to ask, not to memorize a threshold.

Effect size versus statistical significance

An effect can be statistically significant — meaning it is unlikely to be due to chance — and still be too small to matter in everyday life. A 2% relative reduction in a rare outcome, even if 'significant,' may not be a reason to change behavior. Good health journalism reports the absolute effect, not only the relative one.

Ask yourself: out of 1,000 people similar to me, how many would benefit, and by how much? If the article does not let you answer that question, look for one that does.

Statistical significance tells you a result is unlikely by chance. It does not tell you the result matters.
Daniel Okafor, Health Editor

Funding and conflict of interest

Industry funding does not automatically discredit a study, but it is a relevant signal, especially when an investigator's career or company depends on a particular outcome. Reputable journals require disclosures, and reputable journalism reproduces them.

When a study is press-released by the company that paid for it, treat the press release as a marketing document. The study itself, with its disclosures, methods, and limitations sections, is the real document.

What the authors actually say

The discussion and limitations sections of a paper are often the most informative. Researchers routinely name the caveats — short follow-up, small sample, surrogate endpoints — that headlines drop. If a story's certainty exceeds the authors' own, that is a red flag.

Finally, watch the timeline. Early-stage research, including animal studies and small Phase 1 trials, is interesting but rarely actionable. Most findings need replication before they should change clinical practice or personal behavior.

  1. Find the study, not just the press release

    Look for a direct link to the journal article or a DOI. If neither is in the news piece, search PubMed by the authors' names and topic.

  2. Read the abstract, then the limitations

    The abstract states the claim; the limitations section states what the claim cannot do. Both belong in your mental summary.

  3. Translate relative to absolute risk

    If you only see "30% reduction," look for the baseline rate. A 30% drop on a 0.4% baseline is not the same as a 30% drop on a 40% baseline.

  4. Check whether the result has been replicated

    One study is a data point. Two or three independent replications start to look like evidence.

DesignCan answerTypical limits
Randomized controlled trialCausal effect of an interventionCost, ethics, narrow populations
Cohort (observational)Associations over timeConfounding, recall bias
Case-controlRisk factors for rare conditionsSelection bias
Case reportIndividual outcomesCannot generalize
Systematic review / meta-analysisWeight of evidence across studiesOnly as good as included studies
Common study designs and what they can support

Frequently asked questions

How do I find the actual paper behind a news headline?
Reputable articles link directly to the study or name the journal and authors so you can search PubMed. If neither is available, that is itself a signal about the reporting.
Should I act on a single new study?
Rarely. For most personal-health decisions, the better question is whether the new finding is consistent with the existing body of evidence.
What is a preprint and should I trust it?
A preprint is a paper that has been posted publicly before peer review. Preprints can be useful for tracking research, but they should be treated as preliminary.
Do I need to understand statistics to read studies?
Not deeply. Knowing the difference between absolute and relative effect, and being suspicious of very small samples, covers most of the value.
This article is informational — should I still talk to a clinician?
Yes. ClearBrief does not provide medical advice. Use what you read here to ask better questions of your own clinician.

How we researched this

We reviewed the original methods sections of the studies cited, the CONSORT and STROBE reporting guidelines, and standing recommendations from the National Library of Medicine on critical appraisal. We do not provide medical advice; this guide explains how to read research, not what to do about it.

Sources

  1. Understanding Health Research University of Glasgow
  2. PubMed National Library of Medicine
  3. CONSORT Statement for reporting RCTs CONSORT
  4. FDA: How to Understand and Use the Nutrition Facts Label FDA

Corrections

  • April 2, 2026: Clarified that systematic reviews are only as reliable as the studies they include; earlier wording overstated their independence from underlying data quality.

Related reading

What this article does not cover

This article does not evaluate any specific treatment, supplement, or diagnostic test. It is a reading guide, not a clinical reference. For decisions about your own health, talk to a licensed clinician who can review your full history.

Found this useful? Share it with a friend.

This article is informational and not a substitute for professional advice. ClearBrief does not provide medical, legal, or financial services.